| Term 
 | Definition 
 
        | Pro: high titer, non-toxic Con: small genome, non-integrating
 Target: muscle, liver, brain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | big forehead and short limbs autosomal dominant
 lethal in utero to homozygotes
 most common form of dwarfism
 gain of function in FGFR3 gene
 inhibits bone growth
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pro: high titer, cycling independent Con: non-integrating, immune reaction
 Target: cancer, immunization
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | genetic imprinting metnal retardation, seizures, "happy puppet syndrome",
 maternal deletion with paternal imprinted on chromosome 15
 |  | 
        |  | 
        
        | Term 
 
        | Becker Muscular Dystrophy |  | Definition 
 
        | allelic with DMD, less severe, later onset, in-frame mutations, shortened-partially-functional  protein |  | 
        |  | 
        
        | Term 
 
        | Beckwith-Wiedemann Syndrome |  | Definition 
 
        | example of a syndrome defect heterogenous overgrowth (fat baby)
 both IGF2 genes are expressed (maternal is normally imprinted)
 normal intelligence, increased risk of tumors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: alopecia (loss of hair),  ataxia, seizures, deafness, blindness, hypoglycemia, hyperammonemia, acidosis, late childhood or adolescence Inheritance: autosomal recessive, esp. French Canadians
 Biochemical: cannot release biotin from proteins for recycle, biotin is cofactor for 4 hydroxylase
 Treatment: newborn screening, biotin daily
 |  | 
        |  | 
        
        | Term 
 
        | Breast cancer Risk, risk related genes
 |  | Definition 
 
        | Risk in women 1/8 BRCA1: 50-80% breast, 40-60% multifocal brest, 15-45% ovarian
 BRCA2: 50-85% breast, 10-20% ovarian, 6% male breast
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metabolizes wafarin/coumadin Related to VKORC1 gene inhibition
 |  | 
        |  | 
        
        | Term 
 
        | Charcot-Marie-Tooth (CMT) disease, type 1 |  | Definition 
 
        | Symptoms: distal wasting and weakness, loss of reflexes, loss of sensation, onion-bulb Inheritance: autosomal dominant, duplication of struture protein for PNS myelin (PMP-22)
 Biochemical: segmental demyelination of neurons, altered nerve velocity,
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: neonatal onset, elevated sweat chloride, chronic cough, fatty stools, jaundice, clubbing, lung disease and liver failure Inheritance: autosomal recessive (esp. Caucasian), allelic heterogeneity
 CFTR gene (cAMP activated chloride channel), commonly delta-F508 deletion of Phe; plymorphisms of intron 8 (9Ts normal, 5Ts CF)
 Biochemical: effects outwardly retifying chloride channels and a sodium channel; delta-F508 has abnormal protein folding -> impaired protein trafficking
 Treatment: depends on type of defect
 |  | 
        |  | 
        
        | Term 
 
        | Cytochrome P450 2D6 (CYP2D6) |  | Definition 
 
        | Metabolizes codeine to morphine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Low AFP, low uE3, high hCG, high inhibin, low PPAP-A in first trimester |  | 
        |  | 
        
        | Term 
 
        | Duchenne Muscular Dystrophy |  | Definition 
 
        | Symptoms: 3-6years onset, muscle wasting, Gower sign (rise with press on thighs), walk on toes, pseudo-hypertrophy of calves, resp. or cardiac failure, elevated creatine kinase Inheritance: x-linked recessive, 33% new mutations, 15% germline mosaic of mom, DMD gene
 Biochemical: dystrophin protein part of muscle and neuron cytoskeleton and ECM
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | split hand deformity locus heterogeneity
 reduced penetrance (80%)
 |  | 
        |  | 
        
        | Term 
 
        | Edwards syndrime Tri 18 positive tests |  | Definition 
 
        | Low AFP, low uE3, low hCG, low PPAP-A |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | skin hyperextensibility different mutations at different loci
 auto dom, auto rec, X-linked
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DNA hypomethylation: microsatelite instability, oncogene activation, loss of imprinting X-chromosome inactivation
 DNA Hypermethylation: silence tumor suppressor gene
 |  | 
        |  | 
        
        | Term 
 
        | Familial Hypercholesterolemia |  | Definition 
 
        | more severe if homozygous lots of cholesterol  (shows up earlier)
 xanthomas (deposits of cholesterol in skin and tendons)
 |  | 
        |  | 
        
        | Term 
 
        | Family adenomatous polyposis (FAP) Apdenomatous polyposis coli (APC)
 |  | Definition 
 
        | Symptoms: benign adenomatous polyps in first two decades, one(+) polyp malignant Inheritance: auto dom, APC (tumor supressor gene)
 Biochemical: beta catenin activated w/o APC, more proliferative gene expression
 Treat: remove colon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | growth deficiency, brain malformation, short palpebral fissures, thin upper lip, smooth philtrum, behavior problems tetratology related
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: mental retardation, large head, prominent jaw after puberty, large testes, autistic features Inheritance: triplet nucleotide expansion of FMR1, normal transmitting males (carriers with normal pheno); 50-200 repeats prrmutation, >200 repeats mutant, mostly maternal transmission
 Biochemical: loss of function of FMRP involved in mRNA transport in neural cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: vomiting and refusal to fee after first milk, liver disease, lethargy, cataracts, sepsis Inheritance: autosomal recessive, locus heterogeneity, GALT mutation (Gln188Arg, missense, inactive protein); Duarte allele (Asn314Asp, 50% activity)
 Biochemical: deficiency of galactose 1-P uridyltransferase (GALT), glactokinase (cataracts only) or epimerase; high levels of galactose is toxic
 Treatment: galatactose-free diet (lactose-free formula)
 |  | 
        |  | 
        
        | Term 
 
        | HNCPP Hereditary non-polyposis colon cancer
 (Lynch syndrome)
 |  | Definition 
 
        | Symptoms: Inheritance: auto dom, 5-10% CRC, 80% penetrance, late onset, mutant mismatch repair genes, LOH
 Biochemical: microsatellite instability, increased rate of mutations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hereditary neuropathy with liability to pressure palsies Symptoms: episodic numbess, atrophy with minor trauma
 Inheritance: deletion of PMP-22
 |  | 
        |  | 
        
        | Term 
 
        | Hardy-Weinburg Equilibrium |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: frequent bleeding, bleeding to joints Inheritance: x-linked recessive, clotting factor VII gene, often inversion type mutation
 Biochemical: minor symptoms with 5% activity, full disease <1% activity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pro: high titer, large genome Con: non-integrating, ? Toxicity
 Target: CNS, cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | failure of midface and forebrain to develop well most common congenital brain defect
 lots of causes, hedgehodge mutation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: long/thin habitus, downward lens dislocation, thomboembolism, joints are tight Inheritance: autosomal recessive with locus heterogeneity
 Biochemical effect: deficiency/loss of cystathionine synthase (converts homocystein to cystathionine, uses pyridoxal phosphate cofactor)
 results in excess homocysteine and impairs disulfide bridging of FBN1
 Treatment: vitamin therapy and pyridoxine used as treatments, betaine (covert homocystein to methionine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: progressive abnormalities, involuntary movements, agression, apathy, psychosis, 15-18 yrs post-dx Inheritance: autosomal dominant, late onset, expanded repeat in HTT gene coding region, few new mutations, 40-55 repeats = late onset, >60 = juvenile onset
 Biochemical: Huntingtin protein accumulates in nucleus with gain of function affecting rate of neuron decay
 |  | 
        |  | 
        
        | Term 
 
        | Indiana new born screening |  | Definition 
 
        | PKu, galactosemia, maple syrup urine disease, homocystinuria, biotinidase deficiency, hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis, and sickle cell anemia |  | 
        |  | 
        
        | Term 
 
        | Leber hereditary optic neuropathy (LHON) |  | Definition 
 
        | disease of mitochondria results in blindness due to optic nerve degeneration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pro: integrates, non-toxic Con: insertional mutagenesis
 Target: bone marrow, other stem cells, T cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: red-orange sand in diapers, hyperuricemia, self-mutilation, gout, kidney stones Inheritance: x-linked recessive
 Biochemical: deficiency of HPRT (part of purine salvage), buildup of (hypo)xanthine and uric acid
 Treat: allopurinol (prevent uric acid build up)
 |  | 
        |  | 
        
        | Term 
 
        | Maple syrup urine disease (MSUD) |  | Definition 
 
        | Symptoms: normal at birth, first week of life -> lethargy, weight loss, acidosis, hyperammonemia, sweet urine odor Inheritance: autosomal recessive
 Biochemical: deficiency of BCKA DH (6 gene complex), accumulation of BCAA and BCKA --> ketoacidosis and neurological toxicity
 Treatment: diet low in leucine, regular monitor Leu, Iso, Val; liver transplant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | tall/thin, large hands and long thin fingers upward lens dislocation
 dissecting aneurysms, valvular incompetence
 autosomal dominant with pleiotropy and variable expressivity, heterogeneity
 defect in Fibrillin-1 gene (glycoprotein of microfibrils in ECM)
 25-35% de novo mutations
 haploinsufficiency and dominant-negative effects
 overactivity of TGF-beta from lack of FBN1
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: progessive muscle wasting (begins in face), unable to relax after contract (myotonia), early cataracts Inheritance: autosomal dominant, anticipation, DMPK gene (inc. repeats in 3' noncoding region), trans dominant RNA
 Biochmical: extra repeats cause wtong splicing 9 of a chloride channel -> hyperexcitability of skeletal m.,
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | largest impact of single malformations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: multiple fleshy tumors in skin, cafe-au-lait spots, lisch nodules, Inheritance: autosomal dominant, variable expressivity, pleiotropic (affects many tissues), allelic heterogeneity, loss of heterogeneity
 |  | 
        |  | 
        
        | Term 
 
        | Newborn Screening Criteria |  | Definition 
 
        | 1. well defined and high population frequency 2. w/o treatment has high morbidity/mortality
 3. treatment/intervention available
 4. asymptomatic at early stages
 5. rapid, inexpensive, specific, highly sensitive test
 6. public health infrastructure
 |  | 
        |  | 
        
        | Term 
 
        | Osteogenesis Imperfecta Type II |  | Definition 
 
        | autosomal dominant, mostly new mutations brittle bones, large unmineralized skull
 perinatal lethal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | genetic imprinting mental retardation, hypotonia, short stature, compulsive overeating, obesity
 parental deletion with maternal imprint on chromosome 15
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: mousy body odor/urine, hyperyphenylalnienemia, developmental delays, microcephaly, fair skin, eczema Inheritance: autosomal recessive, allelic heterogeneity (likely compound heterozygotes), locus heterogeneity
 Biochemical: deficiency of phenylalanine hydroxylase (converts phenylalanine to tyrosine, uses BH4 as cofactor); high Phe levels inhbits transport of neutral aa across BBB
 Treatment: screening (onset by 6 months, has already effected mental development), dietary Phe restriction, lifetime
 |  | 
        |  | 
        
        | Term 
 
        | Polycystic kidney disease |  | Definition 
 
        | Symptoms: bilateral kidney cysts, hypertension, blood in urine, kidney stones Inheritance: autodomal dominant, late onset, mutations in PKD1, allelic heterogeneity, second hit needed
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pro: integrates, non-toxic Con: insertional mutagenesis
 Target: bone marrow, other stem cells, T cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms: onset 6-18 months, slow head growth, loss of milestones, washing/wringing/squeezing hands Inheritance: x-linked dominance, variable expressivity, most sporadic paternal mutation to MeCP2
 Biochemical: loss of MeCP2 leads to inappropriate expression of genes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a sequence defect U-shaped cleft palate and small mandible
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | developmental regulatory gene |  | 
        |  | 
        
        | Term 
 
        | Thiopurine methyltransferase (TPMT) |  | Definition 
 
        | Metabolizes thoopurine class of chemotherapies |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cleft lip and possible cleft palate and/or lip pits reduced penetrance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | variable expressive white forelock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | number of different alleles at same locus give same physical phenotype most diseases
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenomenon where there is progressively earlier onset and/or increased severity of disease with successive family generations Ex: mytonic dystrophy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of multiple birth defects low frequency clustering of defects but no clear connection between them
 |  | 
        |  | 
        
        | Term 
 
        | autosomal dominant disorders |  | Definition 
 
        | Huntingon, Alzheimer, Neurofibromatosis, Marfan, Hypercholesterolemia, Myotonic dystrophy, PCKD, Achondroplasia |  | 
        |  | 
        
        | Term 
 
        | autosomal recessive diseases |  | Definition 
 
        | Cystic Fibrosis, congenital deafness, Tay-Sachs, Sickle cell, Phenyltonuria |  | 
        |  | 
        
        | Term 
 
        | carrier frequency (recessive) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2 different mutant allele's at same locus |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | heart defects, hearing loos, eye abnormalities "Blueberry muffine baby"
 mother infected, pass to baby
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inbreeding, increased chances of getting autosomal recessive disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of single birth defect mechanical stress to normal tissue
 altered form like a dent in the skull
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of single birth defect breakdown of normal tissues
 necrosis, amputation by amniotic band
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of single birth defect abnormal developmetn of specific fetal tissue
 ex: achondroplasia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | when germ cells are made they pick up a couple mitochondria at random to make an oocyte those mitochondria are then amplified
 few selected, then multiplied greatly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | one allele on and the other is off certain genes from mother or father are turned off
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | gonad cells, multiple gametes can inherit mutation and pass along parent unaffected with multiple affected offspring
 ex: Neurofibromatosis 1
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | two different homologs from same parent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cell whose mtDNA is different |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cell whose mtDNA is identical |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | two copies of same homolog from same parent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Huntington, Alzheimer, Breast cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mutations at different loci give same clinical phenotypes ex: Ehlers Danlos Syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | skewed x-inactivation one X inactivated early in embryo
 same X inactivated in descendant cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of single birth defect disorder of tissue development
 usually during first trimester
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | individual or tissue can have two different sets of genes in their cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not all individuals with disease present with clinical symptoms #affected/totalwithmutation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of multiple birth defects single anomaly that cascades and causes a bunch of other anomalies
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | phenotypic expression of an allele related to the chromosomal sex of the individual |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | most cells normal, but one line of offspring of cells has mutation non-inheritable effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type of multiple birth defects recognized pattern of defects from a specific genetic etiology
 ex: Down syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | study of birth defects and their causes several factors determine a specific sitmulus's tetratologenicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | if enough mitochondria in a cell have mutant alleles, then the cell will be symptomatic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | both homologs of a chromosome pair come from the same parent nondisjunction during meiosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the expression of the disease is variable between individuals common to genes that affect multiple systems
 Ex: Waardenburg Syndome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | seen more often in females |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | more often found in males ex: color blindness
 |  | 
        |  |